Kevin J. Kenny Net Worth

The estimated Net Worth of Kevin J. Kenny is at least $7.23 millió dollars as of 8 January 2024. Mr Kenny owns over 5,959 units of Orthofix Medical Inc stock worth over $2,563,385 and over the last 14 years he sold OFIX stock worth over $3,786,696. In addition, he makes $882,142 as Pres of Global Spine Bus. at Orthofix Medical Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Kenny OFIX stock SEC Form 4 insiders trading

Mr has made over 35 trades of the Orthofix Medical Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently he exercised 5,959 units of OFIX stock worth $103,687 on 8 January 2024.

The largest trade he's ever made was selling 24,441 units of Orthofix Medical Inc stock on 15 November 2016 worth over $635,710. On average, Mr trades about 2,331 units every 64 days since 2011. As of 8 January 2024 he still owns at least 147,321 units of Orthofix Medical Inc stock.

You can see the complete history of Mr Kenny stock trades at the bottom of the page.

Mr. Kevin J. Kenny biography

Kevin J. Kenny is the Pres of Global Spine Bus. at Orthofix Medical Inc.

What is the salary of Mr Kenny?

As the Pres of Global Spine Bus. of Orthofix Medical Inc, the total compensation of Mr Kenny at Orthofix Medical Inc is $882,142. There are 4 executives at Orthofix Medical Inc getting paid more, with Jon Serbousek having the highest compensation of $4,076,200.

How old is Mr Kenny?

Mr Kenny is 56, he's been the Pres of Global Spine Bus. of Orthofix Medical Inc since . There are 8 older and 8 younger executives at Orthofix Medical Inc. The oldest executive at Orthofix Medical Inc is Ronald Matricaria, 77, who is the Independent Chairman of the Board.

What's Mr Kenny's mailing address?

Kevin's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.

Insiders trading at Orthofix Medical Inc

Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth és Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.

What does Orthofix Medical Inc do?

orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing

Complete history of Mr Kenny stock trades at Cardiovascular Systems és Orthofix Medical Inc

Orthofix Medical Inc executives and stock owners

Orthofix Medical Inc executives and other stock owners filed with the SEC include:

• Jon Serbousek,
  President, Chief Executive Officer, Director
• Douglas Rice,
  Chief Financial Officer
• Kimberley Elting,
  Chief Legal and Administrative Officer
• Jon C. Serbousek,
  Pres, CEO & Director
• Kevin J. Kenny,
  Pres of Global Spine Bus.
• Douglas C. Rice,
  CFO & Chief Accounting Officer
• Kimberley A. Elting,
  Chief Legal & Devel. Officer
• Ronald Matricaria,
  Independent Chairman of the Board
• Paul W. Gonsalves,
  Pres of Global Orthofix Orthopedics
• Michael Paolucci,
  Independent Director
• James Hinrichs,
  Independent Director
• Alexis Lukianov,
  Independent Director
• Maria Sainz,
  Independent Director
• Lilly Marks,
  Independent Director
• John Sicard,
  Independent Director
• Paul Gonsalves,
  President of the Orthofix Global Extremities
• Jason Hannon,
  Independent Director
• Kevin Kenny,
  President, Global Orthofix Spine
• Suzanne Armstrong,
  VP of HR
• Jill Mason,
  Chief Ethics & Compliance Officer
• Dan E. Yarbrough,
  VP of Investor Relations
• Tim McGuire,
  Chief Information Officer
• Dr. James T. Ryaby B.A., Ph.D., Chemistry,
  Chief Scientific Officer
• Roberto Donadello,
  Sr. VP, Global Operations
• Michael Finegan,
  
• Robert Allen Ii Goodwin,
  President Biologics
• Rice Doug,
  CFO
• Raymond Fujikawa,
  President Spine Fixation
• Davide Bianchi,
  President, Global Extremities
• Guy J Jordan,
  Director
• Anthony Francis Martin,
  Director
• Luke T Faulstick,
  Director
• Bradley V. Niemann,
  President of Global Spine
• Jeffrey Schumm,
  SVP,General Counsel
• Charles R. Kummeth,
  
• John J. Bostjancic,
  CFO
• Keith Valentine,
  President & CEO
• John B Iii Henneman,
  
• Patrick L Keran,
  Chief Legal Officer
• Stuart Essig,
  Director
• Brad Mason,
  CEO
• Massimo Calafiore,
  President & CEO
• Eric M Brown,
  Sr.V.P. of Sales and Marketing
• De Paul Alberto C Dabreu,
  Director
• John W Littlechild,
  Director
• Cooper Robert Gaines,
  Chairman
• Davey Scoon,
  Director
• Emily Buxton,
  Int. Chief Financial Officer
• James Gero,
  Director
• Wartburg Walter P Von,
  Director
• Randy H Thurman,
  Director
• Mark A Heggestad,
  Chief Financial Officer
• Michael Mainelli,
  Director
• Scott Dodson,
  President, Orthopedics
• Kenneth R Weisshaar,
  Director
• Kathleen T Regan,
  Director
• Thomas M Hein,
  Chief Financial Officer
• Gary Henley,
  President, Americas Division
• Peter J Hewett,
  Director
• Oliver Burckhardt,
  President, International Div
• Alan Milinazzo,
  Chief Operating Officer
• Galvin Mould,
  President, International Div
• Frederik Hartsuiker,
  Director
• Edgar Wallner,
  Deputy Chairman
• Peter Clarke,
  Executive Vice President
• Robert S Vaters,
  Chief Financial Officer
• Stefan Widensohler,
  Director
• Thomas J Kester,
  Director
• Timothy M Adams,
  Chief Financial Officer
• Charles Federico,
  President & CEO
• Vicente Trelles,
  SVP-Worldwide Operations
• Eric Brown,
  President, Spinal Stimulation
• Michael Simpson,
  President, Orthofix Inc.
• Bradley R Mason,
  President of Breg
• Brian Mc Collum,
  Interim CFO
• Jerry Benjamin,
  Director
• Raymond C Kolls,
  VP & General Counsel
• Bryan Mcmillan,
  President, Spine GBU
• Brad Lee,
  President, Breg
• Luigi Ferrari,
  President, Int'l Fixation
• Shweta Maniar,
  
• Julie Andrews,
  CFO
• Patrick Fisher,
  President, Global Orthopedics
• Jorge Andres Cedron,
  CLO
• Wayne Burris,
  
• Thomas A. West,
  Director
• Puja Leekha,
  CECO & Interim CLO
• Geoffrey C Gillespie,
  CAO
• Catherine M Burzik,
  
• Alan Lee Bazaar,
  
• Max Reinhardt,
  President, Global Spine